Emerging Infectious Disease Global Market Trends 2022: Planning for Future Large Scale Infections Pivotal for Businesses
Dublin, Oct. 03, 2022 (GLOBE NEWSWIRE) -- The "Emerging Infectious Disease Market Trends, 2022" report has been added to ResearchAndMarkets.com's offering.
The search for the next large-scale emerging disease was on before the COVID-19 pandemic. Respiratory diseases were among those suggested by Kalorama Information and other outlets and medical associations as possibilities for the next threat. The search is constant and is by no means limited to respiratory epidemics.
As the recent monkeypox concern has demonstrated, little-known pathogens can emerge and become large health threats. This necessitates the development of tests at laboratories. For business planners, it's worthwhile to have a resource describing the possible next pathogens of serious concern.
Emerging Infectious Disease Market Trends, 2022 is designed to provide a substantial look at Emerging Infectious Disease Trends with market numbers for significant categories.
This report includes:
The Market in 2022 and the Forecast for 2027 for Diagnostics for Emerging Infections
Discussion of Scores of Emerging Infectious Diseases of Various Categories Including:
Viral
Bacterial
Mosquito-Borne
Tick-Borne
Animal-Borne
Water/Fecal Transmission
and Other Diseases
2022 Market Estimates for:
Tuberculosis
Malaria
Lyme
Dengue
Other Emerging Diseases
Further Market Breakout for Mosquito-Borne and Tick-Borne Diseases
Diseases Identified by Major Health Agencies and Governments
The Need for Mosquito Control, Tick-Borne Disease Awareness, the Threat of Island Hopping Diseases and Other Trends
Diagnostic Products on the Market to Test for Emerging Infections
Why is it important to examine the world of emerging infectious diseases? In a 2015 TED Talk, Microsoft creator Bill Gates warned that there was a lack of preparation for a viral epidemic. He predicted that it would be "microbes, not missiles" that would cause significant harm to humans. Now with a global focus on testing, Kalorama's update on all of the other diseases that could spread widely seems relevant. It's not to say that every disease will be like the COVID-19 pandemic - not all will be respiratory threats that can spread quickly. Some pathogens spread through contact or insect vectors, slower but often steadier pattern. Vector-based tests such as Zika and malaria remain worrying and new diseases through that transmission method are troubling. And non-respiratory diseases such as Ebola can still spread quickly from person to person if not tested for and treated quickly.
Fortunately, the IVD industry is ready and companies have the capacity to identify antigen targets and viral or bacterial RNA to be able to build high-sensitivity diagnostic products and produce tests at an ever-increasing rate. This report covers their efforts with existing emerging diseases.
Key Topics Covered:
Chapter 1: Executive Summary
Size and Growth of the Market
Figure 1-1: IVD Market for Emerging Diseases, 2021-2026
Figure 1-2: Market by Major Disease (TB, Malaria, Lyme, Dengue, All Other Emerging Diseases)
Monkey Pox Virus
Chapter 2: Discussion: The State of Emerging Infectious Diseases
Table 2-1: World Health Organization (WHO) Neglected Tropical Diseases
Mosquito Borne Illnesses
Controlling Mosquitos: Key to Disease Prevention
Malaria
Chikungunya
Diagnostics
Yellow Fever
Dengue
West Nile Virus
Zika
Table 2-2: Public Library of Science (PLOS) Major Neglected Tropical Diseases
Infections of High Concern
Tuberculosis
Chagas
Lyme Disease
Marburg virus
Rift Valley Fever
Ebola
Ross River Virus
CCHF
Nipah
Lassa Fever
Possibly Concerning Infections
Saint Louis Encephalitis
MERS
SARS
Variegated Squirrel Bornavirus
Killer Cold/Adenoviridae 14
Heartland Virus
"Disease X"
Chapter 3: Viruses
Chapter 4: Bacterial Infections
Chapter 6: Tick-Borne Disease
Chapter 7: Other Emerging Infectious Diseases
Chapter 8: Markets for Major Emerging Infectious Diseases
Chapter 9: Products on the Market
For more information about this report visit https://www.researchandmarkets.com/r/mg4gnb
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900